Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- PMID: 11553815
- PMCID: PMC58566
- DOI: 10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Abstract
The purpose of this study was to classify breast carcinomas based on variations in gene expression patterns derived from cDNA microarrays and to correlate tumor characteristics to clinical outcome. A total of 85 cDNA microarray experiments representing 78 cancers, three fibroadenomas, and four normal breast tissues were analyzed by hierarchical clustering. As reported previously, the cancers could be classified into a basal epithelial-like group, an ERBB2-overexpressing group and a normal breast-like group based on variations in gene expression. A novel finding was that the previously characterized luminal epithelial/estrogen receptor-positive group could be divided into at least two subgroups, each with a distinctive expression profile. These subtypes proved to be reasonably robust by clustering using two different gene sets: first, a set of 456 cDNA clones previously selected to reflect intrinsic properties of the tumors and, second, a gene set that highly correlated with patient outcome. Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
Figures
Similar articles
-
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.Cancer Res. 2003 Nov 1;63(21):7167-75. Cancer Res. 2003. PMID: 14612510
-
ESPL1 is a candidate oncogene of luminal B breast cancers.Breast Cancer Res Treat. 2014 Aug;147(1):51-9. doi: 10.1007/s10549-014-3070-z. Epub 2014 Aug 3. Breast Cancer Res Treat. 2014. PMID: 25086634
-
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.Breast Cancer Res Treat. 2006 Feb;95(3):243-55. doi: 10.1007/s10549-005-9015-9. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261404
-
[Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].Bull Cancer. 2004 Dec 1;91 Suppl 4:S205-10. Bull Cancer. 2004. PMID: 15899609 Review. French.
-
Molecular evolutionary patterns in breast cancer.Adv Anat Pathol. 2003 Sep;10(5):278-90. doi: 10.1097/00125480-200309000-00003. Adv Anat Pathol. 2003. PMID: 12973049 Review.
Cited by
-
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival.Breast Cancer Res Treat. 2013 Feb;137(3):773-82. doi: 10.1007/s10549-012-2398-5. Epub 2013 Jan 4. Breast Cancer Res Treat. 2013. PMID: 23288347 Free PMC article.
-
Distinct FAK activities determine progenitor and mammary stem cell characteristics.Cancer Res. 2013 Sep 1;73(17):5591-602. doi: 10.1158/0008-5472.CAN-13-1351. Epub 2013 Jul 5. Cancer Res. 2013. PMID: 23832665 Free PMC article.
-
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.Oncotarget. 2015 Aug 21;6(24):20570-7. doi: 10.18632/oncotarget.4135. Oncotarget. 2015. PMID: 26011941 Free PMC article.
-
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.Breast Cancer Res. 2012 Jul 27;14(4):R113. doi: 10.1186/bcr3236. Breast Cancer Res. 2012. PMID: 22839103 Free PMC article.
-
Distinctive gene expression patterns in pregnancy-associated breast cancer.Front Genet. 2022 Aug 10;13:850195. doi: 10.3389/fgene.2022.850195. eCollection 2022. Front Genet. 2022. PMID: 36035177 Free PMC article.
References
-
- Fisher E R, Costantino J, Fisher B, Redmond C. Cancer. 1993;71:2141–2150. - PubMed
-
- Elston C W, Ellis I O. Histopathology. 1991;19:403–410. - PubMed
-
- Torregrosa D, Bolufer P, Lluch A, Lopez J A, Barragan E, Ruiz A, Guillem V, Munarriz B, Garcia Conde J. Clin Chim Acta. 1997;262:99–119. - PubMed
-
- Vollenweider-Zerargui L, Barrelet L, Wong Y, Lemarchand-Beraud T, Gomez F. Cancer. 1986;57:1171–1180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous